Page last updated: 2024-11-02

oxidopamine and Allergic Encephalomyelitis

oxidopamine has been researched along with Allergic Encephalomyelitis in 8 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's3 (37.50)18.2507
2000's3 (37.50)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhowmick, S1
Singh, A1
Flavell, RA1
Clark, RB1
O'Rourke, J1
Cone, RE1
Grebe, KM1
Fainstein, N1
Einstein, O1
Cohen, ME1
Brill, L1
Lavon, I1
Ben-Hur, T1
de Lago, E1
Fernández-Ruiz, J1
Ortega-Gutiérrez, S1
Cabranes, A1
Pryce, G1
Baker, D1
López-Rodríguez, M1
Ramos, JA1
Pál, E1
Yamamura, T1
Tabira, T1
Konkol, RJ2
Wesselmann, U1
Karpus, WJ2
Leo, GL1
Killen, JA2
Roerig, DL1
Leonard, JP1
MacKenzie, FJ1
Patel, HA1
Cuzner, ML1

Other Studies

8 other studies available for oxidopamine and Allergic Encephalomyelitis

ArticleYear
The sympathetic nervous system modulates CD4(+)FoxP3(+) regulatory T cells via a TGF-beta-dependent mechanism.
    Journal of leukocyte biology, 2009, Volume: 86, Issue:6

    Topics: Animals; Antigen-Presenting Cells; Encephalomyelitis, Autoimmune, Experimental; Lymph Nodes; Mice; M

2009
Editorial: regulation of the regulator: sympathetic nervous system control of regulatory T cells.
    Journal of leukocyte biology, 2009, Volume: 86, Issue:6

    Topics: Animals; Antigen-Presenting Cells; Encephalomyelitis, Autoimmune, Experimental; Lymph Nodes; Mice; M

2009
Time limited immunomodulatory functions of transplanted neural precursor cells.
    Glia, 2013, Volume: 61, Issue:2

    Topics: Adrenergic Agents; Animals; Cell Proliferation; Corpus Striatum; Cytokines; Disease Models, Animal;

2013
UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2006, Volume: 16, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Arachidonic Acids; Brain Chemistry; D

2006
Autonomic regulation of experimental autoimmune encephalomyelitis in IL-4 knockout mice.
    Journal of neuroimmunology, 1999, Volume: 100, Issue:1-2

    Topics: Animals; Autonomic Nervous System; Cell Division; Down-Regulation; Encephalomyelitis, Autoimmune, Ex

1999
Suppression of clinical weakness in experimental autoimmune encephalomyelitis associated with weight changes, and post-decapitation convulsions after intracisternal-ventricular administration of 6-hydroxydopamine.
    Journal of neuroimmunology, 1990, Volume: 26, Issue:1

    Topics: Animals; Body Weight; Brain; Catecholamines; Cerebral Ventricles; Cisterna Magna; Decerebrate State;

1990
Hypothalamic noradrenergic pathways exert an influence on neuroendocrine and clinical status in experimental autoimmune encephalomyelitis.
    Brain, behavior, and immunity, 1991, Volume: 5, Issue:4

    Topics: Adrenal Glands; Adrenalectomy; Animals; Corticosterone; Encephalomyelitis, Autoimmune, Experimental;

1991
Central catecholamine neurotoxin administration. 1. Immunological changes associated with the suppression of experimental autoimmune encephalomyelitis.
    Journal of neuroimmunology, 1988, Volume: 18, Issue:1

    Topics: Animals; Catecholamines; Encephalomyelitis, Autoimmune, Experimental; Hydroxydopamines; Immunosuppre

1988